Screener
Aclaris Therapeutics ACRS Single Reportable — Cost Of Revenue Excluding Restructuring Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept acrs:CostOfRevenueExcludingRestructuringExpense.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
| (In thousands) | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Contract research | $356 | $442 | $893 | $887 |
| Licensing revenue | 1,273 | 1,335 | 2,732 | 2,345 |
| Total revenue | 1,629 | 1,777 | 3,625 | 3,232 |
| Cost of revenue | 218 | 515 | 613 | 1,021 |
| Research and development: | ||||
| Bosakitug | 3,335 | 2,847 | 6,476 | 6,231 |
| ATI-052 | 4,899 | 1,418 | 8,080 | 2,037 |
| Modzatinib | 370 | 1,118 | 861 | 2,926 |
Item 1. Financial Statements
FAQ
- What is Aclaris Therapeutics's single reportable — cost of revenue excluding restructuring expense?
- Aclaris Therapeutics (ACRS) reported single reportable — cost of revenue excluding restructuring expense of $218K in Q2 2026.
- How has Aclaris Therapeutics's single reportable — cost of revenue excluding restructuring expense changed year-over-year?
- Aclaris Therapeutics's single reportable — cost of revenue excluding restructuring expense decreased by 57.7% year-over-year, from $515K to $218K.
- What does single reportable — cost of revenue excluding restructuring expense mean?
- Captures the direct costs associated with producing the goods or providing the services that generated the segment's revenue, excluding one-time restructuring charges. This metric is essential for evaluating the direct profitability and operational efficiency of the segment's core activities. Monitoring this helps assess the underlying cost structure of the business unit.
Ask your AI about Aclaris Therapeutics's single reportable — cost of revenue excluding restructuring expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude